Table 4.

Characteristics of primary leukemia cells for in vitro studies

Patient samples	Diagnosis	Disease status	Cytogenetics	FLT3	NPM1	Source	% Blast
AML 01	AML arising from MDS	Status post-azacitidine for MDS	t(3;21), +8	WT	ND	BM	8
AML 02	AML post-ET	Untreated	Del (20q), t(1;19) (q25;q13.3)	WT	WT	BM	21
ALL 03	ALL	First relapse	Normal	ND	ND	PB	60
AML 04	AML	Primary refractory	Normal	WT	WT	BM	25
AML 05	AML	Untreated	Inv(16)	WT	WT	BM	61
AML 06	AML	Untreated	Normal	D835	MUT	PB	90
AML 07	AML	Untreated	Normal	ITD	ND	BM	78
AML 08	AML	Untreated	Normal	WT	MUT	BM	73

FLT3 FMS-like tyrosine kinase 3, NMP1 nucleophosmin 1, MDS myelodysplastic syndrome, ET essential thrombocytosis, WT wild type, ND not done, ITD internal tandem duplication, MUT mutated, BM bone marrow, PB peripheral blood